Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
Price Target
Average
126.54%
Revenue Forecast
Estimate
1185.61%
EBIT
Estimate
--37.90%
Net Income
Estimate
31.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Viridian Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for VRDN of $34.1 , with forecasts ranging from
a
low of
$20 to a high of $56 .
VRDN Lowest Price Target
Wall Street Target
20 USD
32.98%
VRDN Average Price Target
Wall Street Target
34.1 USD
126.54%
VRDN Highest Price Target
Wall Street Target
56 USD
272.34%
REVENUE FORECAST
Revenue Forecast Chart VRDN
EBIT FORECAST
EBIT Forecast Chart VRDN
NET INCOME FORECAST
Net Income Chart VRDN